
Ametek Inc
AMETEK is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for over 95 years and is a component of the S&P 500.
Pays a 0.57% dividend yield.
Current Price
$218.29
-0.16%GoodMoat Value
$148.56
31.9% overvaluedAmetek Inc (AME) Quality Analysis
GoodMoat Analysis
Ametek demonstrates a profile of high profitability and financial strength, with robust operating and profit margins, but its returns on capital are only adequate and its valuation appears elevated. The company's quality metrics are solid, though its competitive moat is not definitively strong based on the provided data.
Read full analysis
AME Profitability
AME Growth
AME Financial Health
AME Quality & Fundamental Analysis
Ametek Inc (AME) is a Industrials company in the Specialty Industrial Machinery industry, listed on NYSE. This quality analysis page evaluates Ametek Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Ametek Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 20.00% and a return on equity (ROE) of 13.93%. Return on assets (ROA) stands at 9.21%.
The debt-to-equity ratio is 0.21, with a current ratio of 1.06. Operating margin is 25.81%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Ametek Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.